Skip to main content

Advertisement

Springer Nature Link
Log in

The renoprotective effect of l-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Purpose

Arterial hypertension is associated with a high production of reactive oxygen species and a decrease in the antioxidant defense systems. Based on the lack of toxicity of l-carnitine (LC) and previous studies reporting beneficial effects of this compound in experimental models of hypertension, the aim of this work was to test the hypothesis that LC might protect the kidney against hypertension-induced oxidative damage, as well as to investigate the mechanisms involved in this effect. To this end, specific activities and protein/mRNA expression of the antioxidant enzymes (glutathione peroxidase, glutathione reductase, and superoxide dismutase), and those of NADPH oxidase (the main responsible for superoxide anion production in renal tissue) have been measured in renal cortex homogenates from NG-nitro-l-arginine methyl ester (L-NAME)-treated rats and control normotensive rats. In addition, components of the renin–angiotensin system (RAS) and redox-sensitive transcription factors (NF-κB, Nrf2, and PPARα) have also been evaluated.

Methods

Male Wistar rats aged 6–8 weeks were divided into four groups of six animals each: (1) control, normotensive Wistar rats (with free access to tap water); (2) Wistar rats subjected to treatment with 25 mg of L-NAME/kg body weight/day dissolved in the drinking water, in order to develop L-NAME-induced hypertension; (3) Wistar rats subjected to treatment with 400 mg of LC/kg body weight/day (also dissolved in the drinking water); and (4) L-NAME-treated rats subjected to simultaneous treatment with LC at the indicated doses.

Results

The beneficial effect of LC supplementation on oxidative damage in the renal cortex of hypertensive rats reversed hypertension-associated renal function damage and produced an upregulation of both antioxidant enzymes and eNOS, and with a downregulation of both NADPH oxidase and RAS components. LC improves the oxidative stress response through a specific modulation of NF-κB, Nrf2, and PPARα transcription factors. Thus, the low production of superoxide anions, subsequent to NADPH oxidase inhibition, might act by increasing the expression of Nrf2 and PPARα and by decreasing that of NF-κB, which, in turn, would enhance the antioxidant defense systems.

Conclusions

Our results might support the use of LC to prevent hypertension-induced renal damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Touyz RM (2004) Reactive oxygen species and angiotensin II signaling in vascular cells-implications in cardiovascular disease. Braz J Med Biol Res 37:1263–1273

    Article  CAS  Google Scholar 

  2. Manning RD Jr, Tian N, Meng S (2005) Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25:311–317

    Article  CAS  Google Scholar 

  3. Gomez-Amores L, Mate A, Miguel-Carrasco JL, Jimenez L, Jos A, Camean AM, Revilla E, Santa-Maria C, Vazquez CM (2007) l-Carnitine attenuates oxidative stress in hypertensive rats. J Nutr Biochem 18:533–540

    Article  CAS  Google Scholar 

  4. Mate A, Miguel-Carrasco JL, Monserrat MT, Vazquez CM (2010) Systemic antioxidant properties of l-carnitine in two different models of arterial hypertension. J Physiol Biochem 66:127–136

    Article  CAS  Google Scholar 

  5. Briones AM, Touyz RM (2010) Oxidative stress and hypertension: current concepts. Curr Hypertens Rep 12:135–142

    Article  CAS  Google Scholar 

  6. Sedeek M, Hebert RL, Kennedy CR, Burns KD, Touyz RM (2009) Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 18:122–127

    Article  CAS  Google Scholar 

  7. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubina P, Lahera V, Luno J (2008) Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int 74(Suppl 111):S4–S9

    Google Scholar 

  8. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND (2003) Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41:341–346

    Article  CAS  Google Scholar 

  9. Garrido AM, Griendling KK (2009) NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302:148–158

    Article  CAS  Google Scholar 

  10. Zicha J, Dobesova Z, Kunes J (2006) Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertens Res 29:1021–1027

    Article  CAS  Google Scholar 

  11. Cediel E, Sanz-Rosa D, Oubina MP, de las Heras N, Gonzalez Pacheco FR, Vegazo O, Jimenez J, Cachofeiro V, Lahera V (2003) Effect of AT1 receptor blockade on hepatic redox status in SHR: possible relevance for endothelial function? Am J Physiol Regul Integr Comp Physiol 285:R674–R681

    Google Scholar 

  12. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N (2009) PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest 89:47–58

    Article  CAS  Google Scholar 

  13. Mate A, Miguel-Carrasco JL, Vazquez CM (2010) The therapeutic prospects of using l-carnitine to manage hypertension-related organ damage. Drug Discov Today 15:484–492

    Article  CAS  Google Scholar 

  14. Arduini A, Bonomini M, Savica V, Amato A, Zammit V (2008) Carnitine in metabolic disease: potential for pharmacological intervention. Pharmacol Ther 120:149–156

    Article  CAS  Google Scholar 

  15. Emami Naini A, Moradi M, Mortazavi M, Amini Harandi A, Hadizadeh M, Shirani F, Basir Ghafoori H, Emami Naini P (2012) Effects of oral l-carnitine supplementation on lipid profile, anemia, and quality of life in chronic renal disease patients under hemodialysis: a randomized, double-blinded, placebo-controlled trial. J Nutr Metab 2012(510483):1–6. doi:10.1155/2012/510483

  16. Fatouros IG, Douroudos I, Panagoutsos S, Pasadakis P, Nikolaidis MG, Chatzinikolaou A, Sovatzidis A, Michailidis Y, Jamurtas AZ, Mandalidis D, Taxildaris K, Vargemezis V (2010) Effects of l-carnitine on oxidative stress responses in patients with renal disease. Med Sci Sports Exerc 42:1809–1818

    Article  CAS  Google Scholar 

  17. Ruggenenti P, Cattaneo D, Loriga G, Ledda F, Motterlini N, Gherardi G, Orisio S, Remuzzi G (2009) Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-l-carnitine therapy. Hypertension 54:567–574

    Article  CAS  Google Scholar 

  18. Miguel-Carrasco JL, Monserrat MT, Mate A, Vazquez CM (2010) Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats. Eur J Pharmacol 632:65–72

    Article  CAS  Google Scholar 

  19. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  CAS  Google Scholar 

  20. Gómez-Amores L, Mate A, Vázquez CM (2003) l-Carnitine transport in kidney of normotensive, Wistar-Kyoto rats: effect of chronic l-carnitine administration. Pharm Res 20:1133–1140

    Article  Google Scholar 

  21. Marzinzig M, Nussler AK, Stadler J, Marzinzig E, Barthlen W, Nussler NC, Beger HG, Morris SM Jr, Bruckner UB (1997) Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1:177–189

    Article  CAS  Google Scholar 

  22. Jentzsch AM, Bachmann H, Furst P, Biesalski HK (1996) Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20:251–256

    Article  CAS  Google Scholar 

  23. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169

    CAS  Google Scholar 

  24. Carlberg I, Mannervik B (1975) Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475–5480

    CAS  Google Scholar 

  25. Arthur JR, Boyne R (1985) Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sci 36:1569–1575

    Article  CAS  Google Scholar 

  26. Zalba G, Beaumont FJ, San Jose G, Fortuño A, Fortuño MA, Etayo JC, Diez J (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35:1055–1061

    Article  CAS  Google Scholar 

  27. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159

    Article  CAS  Google Scholar 

  28. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408

    Article  CAS  Google Scholar 

  29. Chaves FJ, Mansego ML, Blesa S, Gonzalez-Albert V, Jimenez J, Tormos MC, Espinosa O, Giner V, Iradi A, Saez G, Redon J (2007) Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens 20:62–69

    Article  CAS  Google Scholar 

  30. Gomez-Amores L, Mate A, Revilla E, Santa-Maria C, Vazquez CM (2006) Antioxidant activity of propionyl-l-carnitine in liver and heart of spontaneously hypertensive rats. Life Sci 78:1945–1952

    Article  CAS  Google Scholar 

  31. Duarte J, Jimenez R, O’Valle F, Galisteo M, Perez-Palencia R, Vargas F, Perez-Vizcaino F, Zarzuelo A, Tamargo J (2002) Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens 20:1843–1854

    Article  CAS  Google Scholar 

  32. Pedro-Botet J, Covas MI, Martin S, Rubies-Prat J (2000) Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens 14:343–345

    Article  CAS  Google Scholar 

  33. Saez GT, Tormos C, Giner V, Chaves J, Lozano JV, Iradi A, Redon J (2004) Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens 17:809–816

    Article  CAS  Google Scholar 

  34. Simic DV, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A, Opacic M, Matic D, Ivanovic B, Simic T (2006) Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens 20:149–155

    Article  CAS  Google Scholar 

  35. Annadurai T, Vigneshwari S, Thirukumaran R, Thomas PA, Geraldine P (2011) Acetyl-l-carnitine prevents carbon tetrachloride-induced oxidative stress in various tissues of Wistar rats. J Physiol Biochem 67:519–530

    Article  CAS  Google Scholar 

  36. Ye J, Li J, Yu Y, Wei Q, Deng W, Yu L (2010) l-Carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway. Regul Pept 161:58–66

    Article  CAS  Google Scholar 

  37. Paravicini TM, Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2):S170–S180

    Article  CAS  Google Scholar 

  38. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J (2001) Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38:1395–1399

    Article  CAS  Google Scholar 

  39. Fortuño A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, Zalba G (2004) Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension. J Hypertens 22:2169–2175

    Article  Google Scholar 

  40. Moreno MU, San Jose G, Fortuño A, Beloqui O, Redon J, Chaves FJ, Corella D, Diez J, Zalba G (2007) A novel CYBA variant, the −675A/T polymorphism, is associated with essential hypertension. J Hypertens 25:1620–1626

    Article  CAS  Google Scholar 

  41. Lassegue B, Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285:R277–R297

    CAS  Google Scholar 

  42. Mister M, Noris M, Szymczuk J, Azzollini N, Aiello S, Abbate M, Trochimowicz L, Gagliardini E, Arduini A, Perico N, Remuzzi G (2002) Propionyl-l-carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int 61:1064–1078

    Article  CAS  Google Scholar 

  43. Stasi MA, Scioli MG, Arcuri G, Mattera GG, Lombardo K, Marcellini M, Riccioni T, De Falco S, Pisano C, Spagnoli LG, Borsini F, Orlandi A (2010) Propionyl-l-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production. Arterioscler Thromb Vasc Biol 30:426–435

    Article  CAS  Google Scholar 

  44. Surh YJ, Kundu JK, Na HK, Lee JS (2005) Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 135:2993S–3001S

    CAS  Google Scholar 

  45. Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E (2008) Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33:2444–2471

    Article  CAS  Google Scholar 

  46. Pendyala S, Natarajan V (2010) Redox regulation of NOX proteins. Respir Physiol Neurobiol 174:265–271

    Article  CAS  Google Scholar 

  47. Chen HH, Sue YM, Chen CH, Hsu YH, Hou CC, Cheng CY, Lin SL, Tsai WL, Chen TW, Chen TH (2009) Peroxisome proliferator-activated receptor alpha plays a crucial role in l-carnitine anti-apoptosis effect in renal tubular cells. Nephrol Dial Transplant 24:3042–3049

    Article  CAS  Google Scholar 

  48. Chao HH, Liu JC, Hong HJ, Lin JW, Chen CH, Cheng TH (2011) l-Carnitine reduces doxorubicin-induced apoptosis through a prostacyclin-mediated pathway in neonatal rat cardiomyocytes. Int J Cardiol 146:145–152

    Article  Google Scholar 

  49. Jing L, Zhou LJ, Li WM, Zhang FM, Yuan L, Li S, Song J, Sang Y (2011) Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha) in alcoholic cardiomyopathy. Med Sci Monit 17:BR1–BR9

    Article  CAS  Google Scholar 

  50. San Jose G, Fortuño A, Moreno MU, Robador PA, Bidegain J, Varo N, Beloqui O, Diez J, Zalba G (2009) The angiotensin-converting enzyme insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent superoxide generation: potential implication in hypertension. Clin Sci (Lond) 116:233–240

    Article  CAS  Google Scholar 

  51. Rajasekar P, Viswanathan P, Anuradha CV (2008) Renoprotective action of l-carnitine in fructose-induced metabolic syndrome. Diabetes Obes Metab 10:171–180

    Article  CAS  Google Scholar 

  52. Miguel-Carrasco JL, Mate A, Monserrat MT, Arias JL, Aramburu O, Vazquez CM (2008) The role of inflammatory markers in the cardioprotective effect of l-carnitine in L-NAME-induced hypertension. Am J Hypertens 21:1231–1237

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Instituto de Salud Carlos III-Subdirección General de Evaluación y Fomento de la Investigación, PN de I+D+I 2008-2011 (PS09/01395) and Consejería de Salud, Junta de Andalucía (PI-0034). S. Zambrano, J.L. Miguel-Carrasco, and A. Blanca were supported by the grants from Consejería de Salud, Junta de Andalucía (PI-0034), and Instituto de Salud Carlos III (FIS PS09/01395). We thank the University of Seville’s Centro de Investigación, Tecnología e Innovación (CITIUS) for its technical assistance. We are also grateful to Dra. A. Fortuño for her help with the determination of NADPH oxidase activity.

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

  1. Departamento de Fisiología, Facultad de Farmacia, Universidad de Sevilla, c/Profesor García González 2, 41012, Sevilla, Spain

    Sonia Zambrano, Antonio Jesús Blanca, María Victoria Ruiz-Armenta, José Luis Miguel-Carrasco, Alfonso Mate & Carmen María Vázquez

  2. Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, c/Profesor García González 2, 41012, Sevilla, Spain

    Elisa Revilla & Consuelo Santa-María

Authors
  1. Sonia Zambrano
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Antonio Jesús Blanca
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. María Victoria Ruiz-Armenta
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. José Luis Miguel-Carrasco
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Elisa Revilla
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Consuelo Santa-María
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Alfonso Mate
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Carmen María Vázquez
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Consuelo Santa-María.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zambrano, S., Blanca, A.J., Ruiz-Armenta, M.V. et al. The renoprotective effect of l-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression. Eur J Nutr 52, 1649–1659 (2013). https://doi.org/10.1007/s00394-012-0470-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-012-0470-x

Keywords